𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon-αtherapy May induce insulin autoantibody development in patients with chronic viral hepatitis

✍ Scribed by Enrico Di Cesare; Marcello Previti; Francesco Russo; Santa Brancatelli; Maria Concetta Ingemi; Riccardo Scoglio; Nicola Mazzù; Domenico Cucinotta; Giovanni Raimondo

Publisher
Springer US
Year
1996
Tongue
English
Weight
672 KB
Volume
41
Category
Article
ISSN
0163-2116

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetic variability of hepatitis C virus
Genetic variability of hepatitis C virus in chronically infected patients with viral breakthrough during interferon–ribavirin therapy
✍ I. Vuillermoz; E. Khattab; E. Sablon; I. Ottevaere; D. Durantel; C. Vieux; C. Tr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

## Abstract Little is known about hepatitis C virus (HCV) breakthrough during antiviral therapy, although it would help in understanding HCV resistance to current antiviral treatments. To analyse the implication of virological factors and the vigour of humoral immune responses in this phenomenon, w

Interferon antibodies may negate the ant
Interferon antibodies may negate the antiviral effects of recombinant α-interferon treatment in patients with chronic hepatitis B virus infection
✍ Dr. Anna Suk-Fong Lok; Ching-Lung Lai; Elsie Kit-Yee Leung 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

In a randomized controlled trial of recombinant a-2a interferon for chronic hepatitis B, interferon antibodies developed in 21 (39%) of 54 Chinese adults who received IFN. No correlation was observed between sex, age, pretreatment serum ALT level or liver histological findings and the development of